Please check your internet connection and try again.
# Walethmade bromide
## Overview
"Walethmade bromide" is not a recognized pharmaceutical entity in clinical practice. The name appears to be a misspelling or obfuscated reference to **Aclidinium bromide**, an anticholinergic (long-acting muscarinic antagonist) used primarily as a bronchodilator.
## Primary Indications
Maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
## Adult Dosing
The standard dosage is 400 mcg administered via oral inhalation twice daily (every 12 hours). Do not exceed two inhalations in 24 hours.
## Pediatric Dosing
Not indicated for use in pediatric patients. Safety and efficacy haven't been established.
## Dose Adjustments
No specific dosage adjustments are required for renal or hepatic impairment.
## Contraindications
Hypersensitivity to aclidinium bromide, atropine, or any components of the formulation.
## Adverse Effects
Common: Headache, nasopharyngitis, cough, sinusitis.
Serious: Paradoxical bronchospasm, hypersensitivity reactions (angioedema, urticaria), urinary retention, and worsening of narrow-angle glaucoma.
## Key Drug Interactions
Avoid concurrent use with other anticholinergics (e.g., ipratropium, tiotropium) due to the risk of additive side effects such as urinary retention, constipation, or tachycardia.
## Monitoring
Monitor for signs of paradoxical bronchospasm, worsening of narrow-angle glaucoma symptoms (eye pain, blurred vision), and urinary difficulty. Assess COPD symptom control and baseline lung function.
## Clinical Pearls
Aclidinium bromide is not a rescue medication and should not be used for the relief of acute bronchospasm. Patients must be educated on the proper use of the inhaler device (e.g., Pressair®) to ensure effective delivery. Remind patients to keep the cap on when not in use.
***
**Educational Disclaimer:** This information is for educational purposes. Drug names and indications can be subject to typographical errors or confusion. Always verify specific drug identity, prescribing information, and local clinical protocols via official databases such as DailyMed, Lexicomp, or the manufacturer’s package insert before providing clinical recommendations.
